✦ LIBER ✦

Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta

✍ Scribed by Riccardo Patacchini; Paolo Santicioli; Sandro Giuliani; Paolo Grieco; Ettore Novellino; Paolo Rovero; Carlo Alberto Maggi

Book ID: 110008086
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 122 KB
Volume: 140
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bjp.0705555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The peptidic urotensin-II receptor ligan

The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems

✍ David J Behm; Gerald Stankus; Christopher P A Doe; Robert N Willette; Henry M Sa 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 416 KB

Biliary excretion of olmesartan, an anig

Biliary excretion of olmesartan, an anigotensin II receptor antagonist, in the rat

✍ MOTOE TAKAYANAGI; NAOYO SANO; HAJIME TAKIKAWA 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Endothelial [Ca2+]iis an integrating sig

Endothelial [Ca2+]iis an integrating signal for the vascular tone in rat aortae

✍ Tung-Yi Huang; Hsiun-ing Chen; Chin-Yen Liu; Chauying J Jen 📂 Article 📅 2001 🏛 BioMed Central 🌐 English ⚖ 626 KB

Background: Although various endothelium-dependent relaxing factors (endothelial autacoids) are released upon the elevation of endothelial cytosolic free Ca 2+ concentration (EC [Ca 2+ ] i ), the quantitative relationship between EC [Ca 2+ ] i and vascular tone remains to be established. Moreover, w

The pharmacokinetics and metabolism of D

The pharmacokinetics and metabolism of DuP 532, a non-peptide angiotensin II receptor antagonist, in rats and dogs

✍ Y. N. Wong; K. A. Holm; D. L. Burcham; S.-M. Huang; C. Y. Quon 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 1 views

DuP 532, 2-propy1-4-pentafluoroethyl-l-[ [2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylJ imidazole-5-carboxylic acid, is an orally active, non-peptide angiotensin I1 (AII) receptor antagonist. DuP 532 is more potent and longer acting than losartan, another A11 receptor antagonist currently undergoing ph

The pharmacokinetics and metabolism of C

The pharmacokinetics and metabolism of CP-191,166, an angiotensin II receptor antagonist, in rats and dogs

✍ Mary C. Allen; Mark R. Nocerini; Wesley W. Day 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

166 is an orally active, non-peptide angiotensin II (AII) receptor antagonist developed for the treatment of hypertension and congestive heart failure (CHF). In this study, the intravenous (iv) and oral (po) single dose pharmacokinetics (PK), oral multiple dose PK and P450-mediated metabolism of 16

ChemInform Abstract: Xanthones in Hetero

ChemInform Abstract: Xanthones in Heterocyclic Synthesis. An Efficient Route for the Synthesis of C-3 o-Hydroxyaryl Substituted 1,2-Benzoisoxazoles and Their N-Oxides, Potential Scaffolds for Angiotensin(II) Antagonist Hybrid Peptides.

✍ Yiannis Gardikis; Petros G. Tsoungas; Constantinos Potamitis; Maria Zervou; Paul 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 29 KB 👁 2 views